LIVE MARKETS-Tariff risks, is pharma out of the woods?

Reuters
03 Apr
LIVE MARKETS-Tariff risks, is pharma out of the woods?

STOXX 600 down 1.5%

Trump imposes sweeping tariffs

Banks, luxury, sportswear top fallers

Real estate, utilities up as yields drop

Nasdaq futures down over 3%

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

TARIFF RISKS, IS PHARMA OUT OF THE WOODS?

Pharma stocks are seeing relief today after the space got exempted from Trump's reciprocal tariffs, despite building expectations it would have been targeted instead.

Does this mean the sector is out of the woods?

Probably not, according to UBS.

The Swiss bank continues to see an overhang risk as the sector remains in focus for the U.S. administration.

"In President Trump's speech he outlined 'the Pharma companies are coming back (to the US), because if they don't, they got a big tax to pay'. We believe this highlights his continued appetite to effect change in the industry," it says.

UBS analysts see continued overhang risk for drugmakers.

They say the White House could add a separate round of tariffs specifically targeting pharma, or in a less likely worst-case scenario do something with pricing in a tax bill.

"We don't see Pharma being 'out-of-the-woods' yet," they conclude.

For now, however, relief is palpable.

The broader sector in Europe is broadly steady. London-listed GSK GSK.L and AstraZeneca AZN.L, which have big US revenue exposure, both rose around 2% at one point.

Among US players, UBS highlights AbbVie ABBV.N and Merck MRK.N as companies with significant ex-US  manufacturing.

(Danilo Masoni)

*****

EARLIER ON LIVE MARKETS:

DEFENSIVE BUYING LIMITS THE DAMAGE CLICK HERE

EUROPE BEFORE THE BELL: HEAVY SELLOFF COMING CLICK HERE

SEEMS INVESTORS REALLY DON'T LIKE TARIFFS CLICK HERE

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10